(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: Michael Rea, CEO of Rx Savings Solutions, to discuss the wide gap in Mylan's EpiPen drug pricing between the UK ($69) and the US ($600.)

Wall Street Poised for Bonus Increases in ‘Year of the Bank’
26:24

AMD Soars as AI Demand Fuels Better-Than-Expected Sales Outlook
20:33

Apple Weighs Using Intel, Samsung to Build Device Processors
21:17